REGENXBIO
regenxbio.com
Actively hiring
Rare Disease Therapeutics
Cell & Gene Therapy
As featured in
View 2 jobs
Claim pageClaim
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
News
REGENXBIO's Multi-Catalyst Setup Is Hard To Ignore (Rating Upgrade) (NASDAQ:RGNX)
Regenxbio surged on milestone revenue and EPS beat, with a $313M cash runway to 2027. Click here to read my most recent analysis.
Read more
Report
Bank of America Securities Reaffirms Their Buy Rating on RegenXBio (RGNX)
Detailed price information for Regenxbio Inc (RGNX-Q) from The Globe and Mail including charting and trades.
Read more
Report
Regenxbio outlines cash runway into Q4 2027 as RGX-202 targets module 1 BLA filing in Q3 2026 (NASDAQ:RGNX)
REGENXBIO (RGNX) Q2 2026 earnings call recap: RGX-202 BLA filing timeline, RGX-121 FDA accelerated path, AbbVie retina milestones, cash runway.
Read more
Report
Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and RegenXBio (RGNX)
Detailed price information for Regenxbio Inc (RGNX-Q) from The Globe and Mail including charting and trades.
Read more
Report
REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone
REGENXBIO will receive $100 million from AbbVie for this milestone. "Dosing the first patient in the Phase IIb/III study is a significant milestone in our commitment with AbbVie to bring a one-time gene therapy to patients who continue to face progressive
Read more
Report
US FDA reverses course on Regenxbio's rare-disease gene therapy, backs accelerated approval bid
Read more
Report
Report
REGENXBIO Announces Dosing of First Patient in Phase II AAVIATE Trial of RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery
Read more
Report
REGENXBIO Announces Additional Positive Long-term and Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD
RGX-314 continues to be well-tolerated at all dose levels Long-term, durable treatment effect demonstrated over two years in Cohort 3 Mean improvement in vision and stable retinal thickness 50% of patients remain anti-VEGF injection-free over two years 67
Read more
Report
Show more news
Tech stack
Technologies named in job postings at REGENXBIO over the last 12 months, by layer, with the share of postings for each.
Technologies in use
13
Postings analysed
4
Stack modernity
72/100
Languages
SQL
Python
SAS
Databases
Oracle
Cloud & platforms
Power BI
Tableau
Sign in to see how your skills match this stack
Sign In
Full REGENXBIO tech stack
13 technologies · by team · pay by technology · changes · similar stacks
Salary insights
Compensation ranges based on this company's open jobs
Median
$242k
Typical range
$212k – $406k
Open positions
4
4
Jobs
Architect
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Architect | 4 | $242k | $212k – $406k |
Highest paying role
Vice President, Information Technology
$406k
Normalized to USD per year
Growth
Hiring Momentum
71/100
Growing
Open positions
8
3 opened / 1 closed in 30 days
Median time-to-fill
83 days
faster than 16% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Sales
25% ▼
Leadership
13% ▲
Analytics
13% ▲
HR
13% ▲
Marketing
13% ▼
Public Policy
13% ▲
Activity Timeline
Added Master Data Management to stack
Oct 2026
Added ISO 27001 to stack
Oct 2026
Added Outlook to stack
Sep 2026
Added Microsoft Office to stack
Sep 2026
Added Machine Learning to stack
Sep 2026
Added Waterfall to stack
Sep 2026
Added Tableau to stack
Sep 2026
Added SAS to stack
Sep 2026
Added Python to stack
Sep 2026
Added Power BI to stack
Sep 2026
Added Alteryx to stack
Sep 2026
Added Scrum to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Rockville
Rockville
United States
Sales office
6 open roles 5 posted in 90 days $279k Avg Salary
hires for Leadership, HR, Marketing
Jobs
$285k – $406k per year • Equity • Hybrid • Full-Time • Bachelor's Degree • Rockville
ISO 27001
Analytics
Master Data Management
Apply
$196k – $265k per year • Equity • Remote (United States) • Full-Time • 10+ years exp • Bachelor's Degree
Python
SQL
SAS
Machine Learning
Analytics
Tableau
Power BI
Alteryx
Apply